J.Jpn. Surg. Soc.. 123(1): 89-91, 2022
Proceedings of Special Sessions of Annual Congress
NOVEL COMBINATION IMMUNOTHERAPY AGAINST GASTROINTESTINAL CANCER
|
1) Department of Translational Research and Developmental Therapeutics against Cancer, Yamaguchi University School of Medicine, Ube, Japan Shoichi Hazama1), Koji Tamada2), Naoya Kato3), Michiie Sakamoto4), Hiroaki Nagano5) |
To read the PDF file you will need Adobe Reader installed on your computer.